Akero Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Akero Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2023.
  • Akero Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 69.4M shares, a 24.9% increase year-over-year.
  • Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 52.6M shares, a 34.8% increase from 2022.
  • Akero Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 39M shares, a 11.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 52.6M +13.6M +34.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 39M +4.16M +11.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 34.8M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.